Body Weight  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT00077649: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

Completed
4
188
US
ribavirin [Copegus], peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]
Hoffmann-La Roche
Hepatitis C, Chronic
12/05
12/05
NCT00394277 / 2005-005507-41: A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C

Checkmark EASL 2013: CHARIOT
Apr 2013 - Apr 2013: EASL 2013: CHARIOT
Completed
4
1175
US, Canada, Europe, RoW
peginterferon alfa-2a, Pegasys, Ribavirin, Copegus
Hoffmann-La Roche
Hepatitis C, Chronic
04/09
04/09
NCT00926614: Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Completed
4
20
US
pioglitazone (Actos), Actos, atorvastatin (Lipitor), Lipitor
Brooke Army Medical Center
Hepatitis c
06/11
12/11

Download Options